Evaluation of calibration frequency of common immunoassay biochemical parameters in a tertiary care hospital
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2020 - 2022
Project Lead
Abdu Salam
Authors
Abdu Salam PM, Dr. Jyothi DN, Dr. Girish K Shanthaveeranna, Dr. Anitha Devanath
Project Status
completed
Project Type
Student Project